Signaling pathways in Parkinson's disease: molecular mechanisms and therapeutic interventions.
Ontology highlight
ABSTRACT: Parkinson's disease (PD) is the second most common neurodegenerative disease worldwide, and its treatment remains a big challenge. The pathogenesis of PD may be related to environmental and genetic factors, and exposure to toxins and gene mutations may be the beginning of brain lesions. The identified mechanisms of PD include α-synuclein aggregation, oxidative stress, ferroptosis, mitochondrial dysfunction, neuroinflammation, and gut dysbiosis. The interactions among these molecular mechanisms complicate the pathogenesis of PD and pose great challenges to drug development. At the same time, the diagnosis and detection of PD are also one of obstacles to the treatment of PD due to its long latency and complex mechanism. Most conventional therapeutic interventions for PD possess limited effec
SUBMITTER: Dong-Chen X
PROVIDER: S-EPMC9944326 | biostudies-literature | 2023 Feb
REPOSITORIES: biostudies-literature
ACCESS DATA